Life Insurance With Kidney Disease: Rates, Approval Odds & Best Carriers (2026)

Can You Get Life Insurance With Kidney Disease?

Yes — a kidney disease diagnosis does not make you uninsurable. It changes your rate and narrows which carriers you should apply to, but there is a real product for almost every stage of chronic kidney disease (CKD), from early, stable disease that can qualify for traditional term coverage all the way to dialysis and end-stage renal failure, which still qualify for guaranteed-issue whole life.

We’re an independent brokerage that places high-risk cases every week, and renal files are among the more nuanced we handle. The most expensive mistake kidney patients make is applying blind to the first carrier they find, getting hit with a steep rating or a postponement, and assuming that’s the market’s answer. It usually isn’t. Kidney underwriting hinges on lab numbers that carriers weigh differently — the same medical file can draw a Table 4 offer at one company and a postponement at another.

Two things drive your outcome more than anything else: how well your kidneys still filter (measured by eGFR) and what caused the disease in the first place — because diabetes and high blood pressure, the two leading causes, carry their own ratings on top. Get your eGFR stable and your underlying condition controlled, and even a CKD file can price reasonably. This guide walks through exactly how underwriters read the disease, what each stage actually costs in 2026, and how to route your case to the carrier most likely to say yes.

How Underwriters Stage CKD: eGFR and the CKD Stages

Underwriters don’t just see “kidney disease” on your application — they pull your lab work and grade the disease objectively. The key number is your eGFR (estimated glomerular filtration rate), which measures how many milliliters of blood your kidneys filter per minute. The lower the number, the less filtering capacity remains.

eGFR maps to the five CKD stages, the same framework your nephrologist uses:

CKD Stage	eGFR (mL/min/1.73m²)	How Underwriters Generally Treat It
Stage 1	90+ (with kidney damage)	Best odds — Standard to a low table rating if stable
Stage 2	60-89	Typically Standard to Table 4, depending on cause and trend
Stage 3a	45-59	Table 4-8; some carriers postpone
Stage 3b	30-44	Heavy table rating or postponement
Stage 4	15-29	Traditional coverage rarely available; guaranteed-issue path
Stage 5	Under 15 (or dialysis)	End-stage — guaranteed-issue only

A rough, carrier-friendly rule of thumb we see in practice: an eGFR of 60+ that has held steady often supports Standard to Table 4; eGFR in the 45-59 range tends toward Table 4-8; and eGFR below 45 usually means a postponement or decline for traditional coverage. But the single reading doesn’t decide the case. Underwriters weigh the whole picture:

• The trend, not just the number. A stable eGFR held for two years is viewed far more favorably than the same number falling year over year. Underwriters care more about trajectory than any one lab.
• The underlying cause. Diabetes and high blood pressure cause most CKD, and each carries its own rating that stacks on the kidney rating (covered below).
• Proteinuria / albuminuria. Protein in the urine signals ongoing kidney damage and pushes the rating up, even when eGFR still looks acceptable.
• Comorbidities. CKD rarely travels alone. Coexisting heart disease or uncontrolled blood pressure compounds the rating sharply.
• Stability and follow-up. Consistent nephrology care, medication adherence, and blood pressure kept in range all strengthen your file.

This is why two people who both “have kidney disease” can get completely different offers. The rating is built from the whole picture — cause, stage, trend, and protein — not the diagnosis code.

What Kidney Disease Costs by Stage

CKD is priced as a table rating — a fixed surcharge stacked on top of your base rate class, where each table adds roughly 25%. Here’s how the stages typically rate for an applicant buying $500,000 of 20-year term at age 40, using our published table-rating data:

CKD Profile	Likely Rating	Estimated Monthly Premium
Stage 1-2, stable, cause controlled	Standard to Table 4	~$52-104
Stage 3a, stable eGFR	Table 4-8	~$104-156
Stage 3b or falling eGFR	Table 8 or postpone	~$156+
Stage 4 (eGFR 15-29)	Usually postpone / guaranteed-issue	See below
Stage 5 or on dialysis	Guaranteed-issue only	See below

For reference, that same healthy 40-year-old with no kidney disease pays about $52/month at Standard on our tables. So early, stable CKD with a controlled cause often adds only a modest surcharge — the disease is priced, not punished. For the full breakdown by age and coverage amount, see our diabetic rate tables, which use the same table-rating math.

These are realistic 2026 estimate ranges, not quotes. Your actual offer depends on your full renal file — your eGFR trend, your protein levels, the underlying cause, and, more than anything, on which carrier reviews it.

The wrinkle that catches people off guard: the rating for the kidney disease and the rating for its cause stack. A Stage 2 file that would be Table 2 on its own can land several tables higher once the diabetes or hypertension that caused it is added in — which is exactly why the next section matters so much.

The Diabetes & Blood Pressure Connection

Diabetes and high blood pressure cause roughly two-thirds of all kidney disease in the U.S., and that link changes your underwriting in a way many applicants don’t expect: the underwriter rates the kidney disease and the condition that caused it, and the two ratings compound.

You can see this directly in our own diabetic pricing. On the diabetes rate tables, a 45-year-old with Type 2 diabetes and no complications is Standard — but add Stage 2 kidney disease (diabetic nephropathy) and the same applicant jumps to Table 8, roughly $288/month on a $500K policy. Push the kidney disease to Stage 3 or beyond and most carriers move to a decline. The kidney complication is what turns a manageable diabetic file into a hard one.

The practical takeaway is that controlling the underlying cause is the biggest lever you have on a CKD rating:

• If diabetes is the cause, driving your A1C below 7.0 and documenting a stable eGFR is what separates a table-rated approval from a postponement. Our diabetic life insurance guide and A1C rate estimator walk through the levers.
• If high blood pressure is the cause, getting it medicated and documented as controlled matters enormously — uncontrolled hypertension alongside CKD is what pushes files toward decline. See our high blood pressure guide.
• Either way, protect the eGFR trend. Underwriters reward stability. A cause that’s controlled and a filtration rate that’s holding steady is the profile that gets approved.

The order of operations is simple: get the underlying condition documented as controlled before you apply, so the underwriter sees the whole picture trending in the right direction rather than a snapshot of two uncontrolled problems.

If You’re on Dialysis or Have Had a Transplant

Once dialysis appears in your chart, nearly every fully underwritten and no-exam product closes — dialysis signals end-stage renal failure and high near-term mortality risk. The same is largely true for Stage 4-5 CKD and the first couple of years after a transplant. But “declined for traditional coverage” is not “uninsurable.” You have real options:

• Guaranteed-issue whole life. These policies ask no health questions and cannot decline you for dialysis, advanced CKD, or a recent transplant. Coverage amounts are smaller (typically up to $25,000-40,000) and there’s a two-year graded death benefit — if you die of natural causes in the first two years, the policy refunds your premiums plus interest rather than paying the full face amount; after that, the full benefit is payable. For end-stage disease, this is the reliable way to guarantee money for final expenses, medical bills, and debts. Our burial insurance guide walks through how these policies work.
• Life insurance after a kidney transplant. A transplant actually improves your long-term insurability compared with staying on dialysis. Most carriers want two to three years of stable post-transplant function before considering traditional coverage, and with three to five-plus years of stability plus controlled comorbidities, a table-rated approval is genuinely achievable. Underwriters will want your transplant records, current kidney-function labs, and proof of anti-rejection medication compliance. Until you reach that window, guaranteed-issue or simplified-issue coverage bridges the gap.
• Simplified-issue whole life. A short health questionnaire, no exam. Some applicants with moderate (not end-stage) CKD and no dialysis can qualify, with larger coverage than guaranteed-issue and a shorter graded period at select carriers.

The honest framing: for dialysis and end-stage disease, the goal shifts from “cheapest rate” to “guaranteed coverage in place.” A guaranteed-issue policy that pays beats a traditional application that gets declined, every time. Many of these products can be issued with no medical exam, which matters when a paramedical visit isn’t practical.

Best Carriers for Kidney Disease

There is no universal “best carrier for kidney disease” — the right company depends on your CKD stage, the underlying cause, and your eGFR trend. That said, some carriers are consistently more workable than others:

• Prudential. Strong on impaired-risk files generally and often willing to work early-to-moderate CKD when the cause is controlled and the trend is stable.
• Banner Life (Legal & General). Competitive base term pricing that carries through even with a table rating, good for early, stable CKD in an otherwise healthy applicant.
• Corebridge Financial (formerly AIG). Among the more accommodating for moderate impaired-risk cases, including some Stage 2-3 files with strong documentation.
• Mutual of Omaha. The go-to for the guaranteed-issue and simplified-issue path — the right answer for dialysis, advanced CKD, or the early post-transplant window, where the goal is a policy that can’t be declined.

For the broader picture on how these companies stack up across health conditions, see our best life insurance companies rankings, and for kidney disease driven by diabetes specifically, our best carriers for diabetics guide.

Just as important is knowing which carriers to avoid applying to blind. Some companies underwrite renal disease strictly and will postpone or decline files that a friendlier carrier would rate and issue — and a decline on your record makes the next application harder. That’s the core reason to pre-screen a kidney case through a broker rather than firing off applications yourself.

How to Get the Best Rate

1. Get your renal labs in order first. Your most recent eGFR, your CKD stage, your urine protein (albuminuria) results, and — critically — your eGFR readings over the past 1-2 years are your strongest evidence. A stable, well-documented trend rates far better than a single number with no history.
2. Control the underlying cause and prove it. If diabetes or high blood pressure caused your CKD, getting it documented as controlled is the biggest single lever on your rating. Underwriters rate the cause and the kidney disease together.
3. Manage the comorbidities. Controlled blood pressure, a healthy weight, and stable cholesterol all take pressure off the rating. CKD combined with an uncontrolled second condition is what pushes files toward postponement.
4. Never apply blind to a single carrier. Renal underwriting is too variable, and a decline follows you. Let a broker pre-screen your file informally with the carriers most favorable to kidney disease before a formal application goes in.
5. Match the product to the stage. Early, stable CKD → shop fully underwritten term. Dialysis or end-stage → go straight to guaranteed-issue rather than collecting declines. Post-transplant → wait for the stability window, then shop traditional.
6. Buy now, re-shop later if you’re stable or improving. The premium on a policy you already own is locked at issue — if your CKD later worsens, your coverage and rate don’t change. And if your eGFR stabilizes or you clear the post-transplant window, you can re-apply for a better rate down the road.

Kidney disease makes life insurance more complicated, not impossible. The difference between a good outcome and a bad one is almost always carrier selection and documentation — and that’s exactly what an independent broker does. Get a free life insurance quote and we’ll match your kidney profile to the carriers most likely to approve it at the best possible rate, and tell you honestly which product fits your stage.

Frequently Asked Questions

Can you get life insurance with chronic kidney disease?

Yes. Applicants with early-stage, stable CKD (Stage 1 or 2, eGFR 60 or higher) and a controlled underlying cause can often qualify for traditional coverage — sometimes Standard, more commonly a table rating. Stage 3 is usually approved at a higher rating or postponed until function stabilizes. Advanced CKD, dialysis, and the period right after a transplant close most traditional products, but guaranteed-issue whole life accepts you regardless. The single most important number is your eGFR, and the trend of that number over time matters as much as the reading itself.

How much does life insurance cost with kidney disease?

It depends on your stage and what caused the disease. A 40-year-old with early, stable Stage 1-2 CKD buying $500,000 of 20-year term might pay roughly $52-104/month — a Standard to Table 4 rating. Stage 3 typically runs Table 4-8 (about $104-156/month for that profile) or a postponement. If diabetes or high blood pressure is the underlying cause, that rating stacks on top. Dialysis or very advanced CKD usually means guaranteed-issue whole life, where a small final-expense policy runs about $40-170/month depending on age and coverage.

Can you get life insurance on dialysis?

Not through traditional or most no-exam policies — active dialysis signals end-stage kidney failure and closes fully underwritten products at essentially every carrier. But you are not uninsurable. Guaranteed-issue whole life accepts you regardless of dialysis, with no health questions and no exam. Coverage is smaller (typically up to $25,000-40,000) and carries a two-year graded death benefit, but it guarantees money is in place for final expenses and debts.

Can you get life insurance after a kidney transplant?

Yes, though most carriers want to see stability first. Traditional coverage generally opens up two to three years post-transplant, and with three to five-plus years of stable function and controlled comorbidities it becomes genuinely achievable — as a table rating, not a decline. Underwriters look at how well your body accepted the kidney, time since surgery, whether the donor was living or deceased, and your anti-rejection medication compliance. Before you hit that window, guaranteed-issue or simplified-issue whole life bridges the gap.

Which life insurance companies are best for kidney disease?

There's no single best carrier — kidney underwriting varies widely, which is exactly why you shop it through a broker. For early, stable CKD, carriers like Prudential, Banner Life, and Corebridge (formerly AIG) tend to be more accommodating on impaired-risk renal files. For dialysis, advanced CKD, or the early post-transplant window, the right answer is usually a guaranteed-issue carrier such as Mutual of Omaha. Avoid applying blind to strict carriers — a decline goes on your record and follows you.